Vera Therapeutics Inc logo

VERA - Vera Therapeutics Inc News Story

$18.68 1.2  7.0%

Last Trade - 26/10/21

Small Cap
Market Cap £288.7m
Enterprise Value £222.2m
Revenue £n/a
Position in Universe 4019th / 7275

Vera Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Mon 16th August, 2021 1:10pm
* Vera Therapeutics Inc  VERA.OQ  reported a quarterly adjusted
loss of 33 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 39 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Vera Therapeutics Inc's reported EPS for the quarter was a
loss of 33 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Vera Therapeutics Inc shares had risen by 27.8% this quarter.
* The company reported a quarterly loss of $3.44 million.
* Wall Street's median 12-month price target for Vera
Therapeutics Inc is $26.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 12:10 p.m.  ​All
figures in US dollars unless otherwise stated
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.